Outcomes of Severe Acute Respiratory Diseases Caused by SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus
Microorganisms · 11.07.2026 · 14 (7) · 1515
DOI: 10.3390/microorganisms14071515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 11.07.2026. Verfasst von Theofani Rimpa und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Critical Care and Pulmonary Medicine, National and Kapodistrian University of Athens, Evaggelismos Hospital, Ιpsilantou 45-47, 1067…. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Account for Research Grants (ELKE) of the National and Kapodistrian University of Athens.
Abstract (Originalsprache)
COVID-19, influenza, and respiratory syncytial virus are leading causes of severe acute respiratory infection (SARI). As viral dynamics shift post-pandemic, comparing their clinical profiles is essential for optimizing management and vaccination strategies. We conducted a retrospective observational study of adults hospitalized with PCR-confirmed COVID-19, influenza, or RSV over three consecutive seasons (2021–2024). We compared clinical features, comorbidities and outcomes, including mortality, intubation rates and respiratory deterioration. Multivariable analyses were performed where virus was the independent variable and respiratory deterioration, intubation rate and mortality, Charlson Comorbidity Index, smoking status and pneumonia were co-variates. 263 patients were analyzed. Key findings revealed distinct clinical profiles: influenza patients were significantly younger, while COVID-19 was the predominant cause of viral pneumonia. RSV patients presented with the most severe oxygenation deficit upon admission and experienced the highest rate of respiratory deterioration (28%). Logistic regression analyses demonstrated that pneumonia [OR 2.81, 95% Confidence Interval (CI): 1.23–6.43, p = 0.01] and RSV (OR 2.8, 95% CI: 1.16–6.63, p = 0.02) were independently associated with respiratory deterioration. Similarly, pneumonia (OR 4.86, 95%CI: 1.62–17.36, p < 0.01] and RSV (OR 4.67, 95%CI: 1.5–14.34, p < 0.01) were independently associated with high risk of intubation. Among patients hospitalized because of COVID-19, RSV and Influenza, pneumonia and RSV were linked with respiratory deterioration and increased risk of intubation but not with death.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1st Department of Critical Care and Pulmonary Medicine, National and Kapodistrian University of Athens, Evaggelismos Hospital, Ιpsilantou 45-47, 10676 Athens, Greece.
- Department of Pulmonary Medicine, 401 General Army Hospital, 11525 Athens, Greece.
ORCID-Profile: Theofani Rimpa, Vasileios Skouras, Apostolos Pappas
Förderung
- Special Account for Research Grants (ELKE) of the National and Kapodistrian University of Athens
Zitieren
APA
Rimpa, T., Skouras, V., Loli, S., Diakonikolaou, Z., Dede, K., Eleftheriou, K., Pappas, A., & Kalomenidis, I. (2026). Outcomes of Severe Acute Respiratory Diseases Caused by SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus. Microorganisms, 14(7), 1515. https://doi.org/10.3390/microorganisms14071515
Vancouver
Rimpa T, Skouras V, Loli S, Diakonikolaou Z, Dede K, Eleftheriou K, et al. Outcomes of Severe Acute Respiratory Diseases Caused by SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus. Microorganisms. 2026;14(7):1515. doi:10.3390/microorganisms14071515
BibTeX
@article{Rimpa2026,
author = {Rimpa, Theofani and Skouras, Vasileios and Loli, Stefania and Diakonikolaou, Zacharias and Dede, Konstantina and Eleftheriou, Konstantinos and Pappas, Apostolos and Kalomenidis, Ioannis},
title = {Outcomes of Severe Acute Respiratory Diseases Caused by SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {7},
pages = {1515},
doi = {10.3390/microorganisms14071515}
}
EUVIMED